|
|
 | | | |
- close
- close
- close
- close
Electro-Optical Sciences (MELA) |
StreetInsider.com
May 1
Comment
This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today.
52-Week High:
Sirius XM (Nasdaq: SIRI) $3.39. Sirius moving higher amid reporting
Benzinga
May 1
Comment
Skullcandy (NASDAQ: SKUL) shares tumbled 4.67% to touch a new 52-week low of $4.90. Skullcandy is expected to report its Q1 earnings on May 2, 2013.
MELA Sciences (NASDAQ: MELA) shares dropped 14.63% to reach a new 52-week low of $1.05 on Q1...
StreetInsider.com
Mar 18
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/MELA+Sciences+%28MELA%29+Enters+%2410M+Loan+Agreement+with+Hercules+Tech+%28HTGC%29/8191400.html for the full story.
Benzinga
Mar 13
Comment
Velti Plc (NASDAQ: VELT) shares touched a new 52-week low of $2.40. Velti posted a loss of $5.18 million in the fourth quarter.
Spectrum Pharmaceuticals (NASDAQ: SPPI) shares dipped 36.40% to reach a new 52-week low of $7.91. Spectrum reported...
StreetInsider.com
Mar 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Mela+Sciences%2C+Inc.+%28MELA%29+Reports+In-Line+Q4+Loss+of+19cShare/8158596.html for the full story.
Benzinga
Feb 12
Comment
Qualys (NASDAQ: QLYS) shares tumbled 17.12% to touch a new 52-week low of $10.54. Qualys issued downbeat Q1 forecast.
PHAZAR CORP (NASDAQ: ANTP) shares fell 9.45% to touch a new 52-week low of $1.63. PHAZAR CORP reported a drop in its FQ2...
StreetInsider.com
Feb 12
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/MELA+Sciences+%28MELA%29+Prices+6.1M+Offering+at+%241.30Share/8083156.html for the full story.
StreetInsider.com
Nov 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Mela+Sciences%2C+Inc.+%28MELA%29+Tops+Q3+EPS+by+4c/7854717.html for the full story.
StreetInsider.com
Sep 24
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/WBB+Securities+Upgrades+MELA+Sciences+%28MELA%29+to+Speculative+Buy/7745876.html for the full story.
Marketwire
Jul 25
Comment
IRVINGTON, NY -- (Marketwire) -- 07/25/12 -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed and is commercializing MelaFind®, today announced that it will release its 2012 second quarter financial results after the
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
